Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Matsuyama
Clinical trial register · Japan

Clinical Trials in Matsuyama, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Nagoya 23 Kashiwa-shi 18 Fukuoka 16 Yokohama 14 Sapporo 13
Narrow the registerReset
Recruitment status
Phase
Site location
Nagoya23 Kashiwa-shi18 Fukuoka16 Yokohama14 Sapporo13
All 92 locations
Target enrolment
to

Trials with a site in Matsuyama

10 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Amgen
Phase 3
950
Matsuyama, Kitakyusyu-shi, Aki-gun, Mito, Naka, Tsuchiura-shi, Kumamoto, Kashiwara-shi
2026-07-29
Recruiting
Amgen
Phase 3
750
Nagoya, Matsuyama, Fukuoka, Kobe, Kanazawa, Kita-gun, Sagamihara-shi, Osaka
2025-11-28
Active, closed
Amgen
Phase 3
350
Matsuyama, Fukuoka, Kurume-shi, Sapporo, Akashi-shi, Niigata, Okayama, Hirakata-shi
2025-08-18
Active, closed
Amgen
Phase 3
1,105
Matsuyama, Kitakyusyu-shi, Aki-gun, Mito, Naka, Tsuchiura-shi, Kumamoto, Kashiwara-shi
2025-03-17
Active, closed
Amgen
Phase 3
707
Nagoya, Kashiwa-shi, Matsuyama, Maebashi, Sapporo, Kanazawa, Sagamihara-shi, Yokohama
2024-12-09
Recruiting
Amgen
Phase 3
450
Nagoya, Chiba, Kashiwa-shi, Matsuyama, Fukuoka, Sapporo, Akashi-shi, Kawasaki-shi
2024-07-17
Active, closed
Amgen
Phase 3
563
Nagoya, Kashiwa-shi, Matsuyama, Fukuoka, Kurume-shi, Sapporo, Akashi-shi, Yokohama
2024-06-05
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
Amgen
Phase 3
404
Nagoya, Kashiwa-shi, Matsuyama, Kurume-shi, Sapporo, Yokohama, Sendai, Niigata
2024-02-20
Recruiting
Amgen
Phase 3
750
Nagoya, Hirosaki-shi, Chiba, Kashiwa-shi, Matsuyama, Toon-shi, Fukuoka, Kitakyushu-shi
2023-11-16
Active, closed
Amgen
Phase 3
509
Nagoya, Kashiwa-shi, Matsuyama, Kurume-shi, Sapporo, Akashi-shi, Yokohama, Sendai
2023-05-31
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/matsuyama

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Matsuyama that also match the filters currently applied.

How many clinical trials are recruiting in Matsuyama?

4 of the 10 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Matsuyama), 10 studies
PhaseStudiesRecruitingShare
Phase 3104100%

Most active sponsors

Lead sponsors with the most studies (Matsuyama)
Lead sponsorStudiesRecruiting
Amgen104
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.